SHELTON, CONNECTICUT / ACCESS Newswire / September 9, 2025 / NanoViricides, Inc. (NYSE American:NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

Over the course of more than two decades, researchers at the University of Bern have developed the so-called "Bern model," a ...